ELV Elevance Health Inc

Price (delayed)

$433.72

Market cap

$102.21B

P/E Ratio

16.1

Dividend/share

$5.72

EPS

$26.94

Enterprise value

$117.34B

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
The company's revenue rose by 11% YoY and by 3.1% QoQ
ELV's gross profit is up by 11% year-on-year and by 3.5% since the previous quarter
Elevance Health's debt has increased by 7% YoY

Key stats

What are the main financial stats of ELV
Market
Shares outstanding
235.65M
Market cap
$102.21B
Enterprise value
$117.34B
Valuations
Price to book (P/B)
2.69
Price to sales (P/S)
0.62
EV/EBIT
12.63
EV/EBITDA
10.56
EV/Sales
0.71
Earnings
Revenue
$165.71B
EBIT
$9.29B
EBITDA
$11.11B
Free cash flow
$10.57B
Per share
EPS
$26.94
Free cash flow per share
$44.59
Book value per share
$161.16
Revenue per share
$699.04
TBVPS
$308.75
Balance sheet
Total assets
$109.17B
Total liabilities
$70.86B
Debt
$25.12B
Equity
$38.21B
Working capital
$18.17B
Liquidity
Debt to equity
0.66
Current ratio
1.44
Quick ratio
1.32
Net debt/EBITDA
1.36
Margins
EBITDA margin
6.7%
Gross margin
17.5%
Net margin
3.9%
Operating margin
5.6%
Efficiency
Return on assets
6%
Return on equity
17.3%
Return on invested capital
20.7%
Return on capital employed
13.7%
Return on sales
5.6%
Dividend
Dividend yield
1.32%
DPS
$5.72
Payout ratio
21.2%

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
-1.47%
1 week
-3.22%
1 month
-1.96%
1 year
-7.73%
YTD
-15.45%
QTD
-0.39%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$165.71B
Gross profit
$28.94B
Operating income
$9.31B
Net income
$6.41B
Gross margin
17.5%
Net margin
3.9%
The company's revenue rose by 11% YoY and by 3.1% QoQ
ELV's gross profit is up by 11% year-on-year and by 3.5% since the previous quarter
The operating income has grown by 8% YoY and by 4.2% from the previous quarter
Elevance Health's net income has increased by 6% YoY and by 3.5% QoQ

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
P/E
16.1
P/B
2.69
P/S
0.62
EV/EBIT
12.63
EV/EBITDA
10.56
EV/Sales
0.71
ELV's P/E is 10% below its last 4 quarters average of 18.1 and 5% below its 5-year quarterly average of 17.2
Elevance Health's EPS has increased by 7% YoY and by 4% QoQ
ELV's price to book (P/B) is 9% lower than its last 4 quarters average of 3.0 but 5% higher than its 5-year quarterly average of 2.6
The equity has increased by 7% YoY and by 2.3% from the previous quarter
The company's revenue rose by 11% YoY and by 3.1% QoQ
ELV's P/S is 10% below its 5-year quarterly average of 0.7 and 10% below its last 4 quarters average of 0.7

Efficiency

How efficient is Elevance Health business performance
Elevance Health's ROIC has increased by 6% YoY and by 2.5% from the previous quarter
Elevance Health's return on sales has decreased by 3.4% YoY
ELV's ROE is up by 2.4% YoY

Dividends

What is ELV's dividend history
DPS
$5.72
Dividend yield
1.32%
Payout ratio
21.2%
Recent dividends

Financial health

How did Elevance Health financials performed over time
The total assets is 54% higher than the total liabilities
The total liabilities is up by 9% year-on-year
ELV's quick ratio is up by 8% year-on-year
Elevance Health's debt is 34% less than its equity
The equity has increased by 7% YoY and by 2.3% from the previous quarter
Elevance Health's debt has increased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.